Skip to main content

Table 1 Clinical features of the patients, their histopathological results, strain ratios, and vascular indices

From: Correlation between semiquantitative sonoelastography and immunohistochemistry in the evaluation of testicular focal lesions

Pt

Age

Clinical features

Serum tumor markers (AFP, LDH, βhCG) at diagnosis

Lesion size (mm)

Histotype

Adjuvant therapy

Strain ratio

Vascular index

1

41

Scrotal pain

Positive (βhCG)

5.7

Embryonal carcinoma

Chemotherapy

56

10%

2

50

Epididymitis, cryptorchidism

Negative

8.6

Classic seminoma

NO

34,5

20%

3

32

Infertility

Positive (βhCG, AFP)

7.9

Embryonal carcinoma

Chemotherapy

16,8

40%

4

35

Infertility, palpable testicular node

Negative

10.4

Classic seminoma

NO

8,57

48%

5

34

Epididymitis

Negative

5.6

Classic seminoma

NO

6,43

42%

6

35

Infertility, palpable testicular node

Negative

10.3

Classic seminoma

NO

3,8

48%

7

35

Infertility

Negative

5.9

Classic seminoma

NO

12,3

35%

8

37

Infertility

Negative

5.8

Leydig cell tumor

NO

12,5

32%

9

38

Infertility

Positive (AFP)

6.5

Mixed germ cell tumor

Chemotherapy

12,5

41%

10

22

Varicocele, palpable testicular node

Negative

6.1

Classic seminoma

NO

6,15

44%

11

28

Varicocele

Negative

7.6

Mixed germ cell tumor

Chemotherapy

3,8

47%

12

41

Infertility

Negative

7.8

Leydig cell tumor

NO

3,44

46%

13

49

Palpable testicular nodule

Negative

9.6

Leydig cell tumor

NO

4,2

48%

14

36

Infertility

Negative

6.9

Anaplastic seminoma

Radiotherapy

2,69

48%

15

42

Infertility

Negative

5.1

Leydig cell tumor

NO

23,2

35%

16

38

Infertility, cryptorchidism

Negative

7.9

Spermatocytic seminoma

NO

58

10%

17

33

Epididymitis

Negative

8.6

Classic seminoma

NO

33.5

20%

18

24

Varicocele, palpable testicular node

Negative

10.2

Classic seminoma

NO

14.8

37%

19

29

Varicocele

Negative

7.4

Classic seminoma

NO

9.47

49%

20

37

Infertility, cryptorchidism

Positive (AFP)

6.5

Mixed germ cell tumor

Chemotherapy and RLND

6.51

43%

21

43

Epididymitis

Negative

4.3

Leydig cell tumor

NO

4.7

48%

22

42

Infertility

Negative

4.6

Classic seminoma

NO

12.6

36%

23

46

Scrotal Pain

Negative

5.4

Leydig cell tumor

NO

11.5

31%

24

22

Varicocele, palpable testicular node

Negative

8.8

Classic seminoma

NO

12.9

41%

25

36

Infertility

Negative

6.3

Classic seminoma

NO

8.2

44%

26

36

Epididymitis, cryptorchidism

Negative

5.6

Anaplastic seminoma

NO

8.8

50%

27

33

Infertility

Negative

6.7

Classic seminoma

NO

5.34

45%

28

39

Scrotal pain

Negative

4.3

Classic seminoma

NO

5.34

48%

29

22

Varicocele, palpable testicular node

Negative

8.7

Classic seminoma

NO

3.79

45%

30

36

Epididymitis

Negative

5.6

Leydig cell tumor

NO

21

30%

  1. Abbreviations: AFP alpha fetoprotein, LDH lactate dehydrogenase, βhCG beta human chorionic gonadotropin, RLND retroperitoneal lymph node dissection.